Clinuvel Pharmaceuticals Limited (CUVL)
NASDAQ: CUVL · Real-Time Price · USD
6.83
0.00 (0.00%)
Jul 30, 2026, 12:05 PM EDT - Market open
Clinuvel Pharmaceuticals Market Cap
Clinuvel Pharmaceuticals has a market cap or net worth of $324.47 million as of July 30, 2026.
Market Cap
324.47M
Enterprise Value
163.32M
1-Year Change
n/a
Ranking
Category
Stock Price
$6.83
ChartMarket Cap Chart
Since July 20, 2026, Clinuvel Pharmaceuticals's market cap has decreased from $371.50M to $324.47M, a decrease of -12.66%. That is a compound annual growth rate of -99.91%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 27, 2026 | 351.90M | 0.86% |
| Jul 24, 2026 | 348.90M | - |
| Jul 23, 2026 | 348.90M | -0.71% |
| Jul 22, 2026 | 351.40M | -0.28% |
| Jul 21, 2026 | 352.40M | -5.14% |
| Jul 20, 2026 | 371.50M | - |
View and export this data all the way back to 2026. Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| DiaMedica Therapeutics | 357.79M |
| Palisade Bio | 350.63M |
| Upstream Bio | 348.29M |
| Fennec Pharmaceuticals | 345.29M |
| Lexeo Therapeutics | 344.71M |
| Abeona Therapeutics | 343.11M |
| Rocket Pharmaceuticals | 342.87M |
| Zentalis Pharmaceuticals | 328.88M |